Skip to main content
Clinical Trials/NCT05097092
NCT05097092
Unknown
N/A

Strength Training Augmenting Rehabilitation - 1

Texas Christian University2 sites in 1 country20 target enrollmentAugust 13, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Muscle Disuse Atrophy
Sponsor
Texas Christian University
Enrollment
20
Locations
2
Primary Endpoint
Changes in muscle size
Last Updated
4 years ago

Overview

Brief Summary

This project aims to determine whether a novel strength training rehabilitation protocol can diminish the negative consequences of limb immobilization and expedite the restoration of muscle function during retraining in healthy individuals.

Detailed Description

The present study will examine the time course of muscle strength and size adaptations in two groups of volunteers during immobilization and retraining. Both groups will undergo temporary muscle disuse by wearing a shoulder sling and swathe on their non-dominant arm for \~≥10 hours/day for four weeks. One group (immobilization + unilateral training) will perform progressive unilateral strength training of the free limb throughout the immobilization period. The other group (immobilization control) will not undergo any training during the immobilization period. Following immobilization, both groups will undergo four weeks of bilateral strength training to retrain the immobilized arm.

Registry
clinicaltrials.gov
Start Date
August 13, 2021
End Date
August 14, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joshua Carr

Assistant Professor

Texas Christian University

Eligibility Criteria

Inclusion Criteria

  • a body mass index between 18 - 35 kg/m2
  • 18-35 years of age
  • right-hand dominant
  • willingness to comply with the immobilization requirements
  • willingness to refrain from strength training outside of the study
  • willingness to comply with the strength training procedures of the study

Exclusion Criteria

  • a personal or family history of blood clots
  • a personal or family history of thyroid disorders
  • previous orthopedic surgeries to the upper limbs and/or joint pain of the upper limbs in the last 6 months
  • neuromuscular or metabolic disorders
  • osteoarthritis
  • use of hormone replacement therapy (ie., testosterone, estrogen, and/or growth hormone pharmaceuticals)
  • pregnancy and/or nursing

Outcomes

Primary Outcomes

Changes in muscle size

Time Frame: Changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

Ultrasound muscle thickness of biceps brachii and triceps brachii

Changes in isometric muscle strength

Time Frame: Changes from baseline at 5 and 10 weeks

MVC (Newton)

Changes in dynamic muscle strength

Time Frame: Changes from baseline at 5 and 10 weeks

1RM (lbs)

Changes in lean mass

Time Frame: Changes from baseline at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 weeks

DEXA

Changes in EMG amplitude

Time Frame: Changes from baseline at 5 and 10 weeks

Surface EMG

Changes in action potential amplitude

Time Frame: Changes from baseline at 5 and 10 weeks

Surface EMG Decomposition

Study Sites (2)

Loading locations...

Similar Trials